For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...